i-med_pharma_logo
animalhealthlogo

Intraocular Lenses, I-Lens®K9 IOLs

k965014mmSince our introduction of the first veterinary intraocular lens almost two decades ago, I-MED Animal Health has continuously raised the bar for veterinary IOLs. Advanced design and materials help make I-MED's veterinary IOLs some the most popular across the world. We continue to work on new innovations to simplify IOL implantation while providing superior long-term results for the patients.

Please contact us for more information or to order I-Lens K9 intraocular lenses.

I-Lens® K9 IOLs FAQ

Expand all | Collapse all

  • What are the benefits of Heparin Surface Modification (HSM)?

    1. Heparin surface-modification (HSM) reduces postoperative inflammatory responses in the early postoperative period.
    2. HSM posterior intraocular lenses result in less cellular response observed one year after extracapsular cataract extraction.
    3. HSM results in reduced foreign-body reaction as measured by specular micrography and slit-lamp examination, especially in the early postoperative period.
    4. Patients who are diabetic or have glaucoma can definitely benefit from an HSM acrylic IOL compared to a non-HSM PMMA IOL, according to a multi-center study.
    5. HSM coating appears to be a valuable tool to decrease implant-associated bacterial endophthalmitis.


    ** Statements taken from industry articles on file.

  • What is Heparin Surface Modification (HSM)?

    The latest development in veterinary intraocular lens (IOL) technology is the heparin surface modification (HSM) of lenses by I-MED. This is an important advance in veterinary ophthalmic technology—and another step into the future of implant surgery by I-MED.

    Heparin is a carbohydrate molecule endogenous to invertebrates and mammals. It is not recognized as a foreign substance by the body, and does not appear to elicit immunologic reactions. In addition, heparin surface modification has been tested on various implantable devices for the purpose of reducing bacterial adhesion and thereby reducing the risk of infection. Referenced articles in scientific literature that elaborate on the benefits of heparin coating are available upon request. The patented heparin surface modification of treated intraocular lenses provides a strong molecular attachment between the heparin and the polymer lens surface.

    Only sterile, medical grade heparin, which is fully tested in accordance with US Pharmacopoeia specifications, is used in this process. To demonstrate the safety of this new process, a battery of in vitro/in vivo tests has been performed according to ISO 10993 Tripartite guidelines, all with good results.

 

  • I-Lens® K9 600s
  • I-Lens® K9 700s
  • I-Lens® K9 650s
k9600

Overall Diameter 14.0, 15.0 or 16.0 mm
Optic Design Biconvex
Optic Diameter 6.0 mm
Angulation Step Vault (7°)
Lens Material PMMA CQ UV
Power Range 41 dp
Positioning Holes 3 - 1 haptic, 2 tab
Sterilisation ETO
k9700

Overall Diameter  15.0, 16.0 or 17.0 mm
Optic Design Biconvex
Optic Diameter 7.0 mm
Angulation Step Vault (10°)
Lens Material PMMA CQ UV
Power Range 41 dp
Positioning Holes 4 - 2 haptic, 2 tab
Sterilisation ETO

k9650

Each I-Lens®  K9 650 (or 650 HSM) comes with a single use injector
Overall Diameter 11.0, 12.0,13.0, or 14.0 mm
Optic Design Biconvex
Optic Diameter 6.5 mm (6.0 mm clear)
Surface Heparin Surface Modified (HSM)
optional
Angulation Square Edge (5°)
Lens Material Hydrophylic acrylic
Power Range 41 dp
Positioning Holes None
Sterilisation Autoclave

Dog Cataract Surgery with an I-Lens® K9 IOL


Performed by Dr. John Sapienza DVM, ACVO Diplomate

You may also be interested in . . .